EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access

Effectiveness of a Web-based and Mobile Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: Randomized Controlled Trial

Wirksamkeit eines webbasierten und mobilen Therapie-Chatbots auf Angst- und Depressionssymptome bei jungen Erwachsenen mit subklinischer Symptomatik: randomisierte kontrollierte Studie

Stanisław Karkosz iD, Robert Szymański iD, Katarzyna Sanna iD, Jarosław Michałowski iD

JMIR Formative Research · 2024-03-20 · 8 · e47960

DOI: 10.2196/47960 ↗

Auf einen Blick

In einer randomisierten Studie mit 81 jungen Erwachsenen mit subklinischer Depression oder Angst reduzierten sich Angst- und Depressionssymptome in beiden Gruppen. Zwischen Chatbot und Selbsthilfegruppe zeigten sich keine Unterschiede.

Fragestellung

Ist der Therapie-Chatbot Fido auf Polnisch wirksamer als ein Selbsthilfebuch zur Reduktion von Angst- und Depressionssymptomen?

Methode

2-armige, offene randomisierte kontrollierte Studie mit 81 Teilnehmenden; experimentell Fido-Chatbot, Kontrolle Selbsthilfebuch; Messung zu Baseline, nach 2 Wochen und nach 1 Monat.

Ergebnisse

Nach der Intervention sanken Depressions- und Angstsymptome in beiden Gruppen (Chatbot: n=36; Kontrolle: n=38) und blieben nach 1 Monat stabil. Einsamkeit unterschied sich nicht signifikant zwischen den Gruppen.

Einschränkungen

Weitere Forschung zu Langzeiteffekt, Real-World-Wirksamkeit und klinischer Stichprobe ist nötig.

Schlussfolgerung der Autor:innen

Die Autor:innen fanden keine Replikation früherer Chatbot-Studien, da beide Arme therapeutische Effekte zeigten. Fido reduzierte Angst und Depression und senkte bei häufigen Nutzer:innen die Einsamkeit.

Kernaussagen

  • Keine Unterschiede zwischen Chatbot und Selbsthilfebuch bei Angst und Depression
  • Symptome nahmen in beiden Gruppen nach 2 Wochen ab und blieben nach 1 Monat stabil
  • Weniger Einsamkeit nur bei häufiger Nutzung des Chatbots in einer explorativen Analyse

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in JMIR Formative Research, published online on 2024-03-20. Written by Stanisław Karkosz and 3 co-authors. Institution: Laboratory of Affective Neuroscience in Poznan, SWPS University, Warsaw, Poland. Cited 86 times so far (Crossref); 50 references. The full text is freely available in PubMed Central.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

There has been an increased need to provide specialized help for people with depressive and anxiety symptoms, particularly teenagers and young adults. There is evidence from a 2-week intervention that chatbots (eg, Woebot) are effective in reducing depression and anxiety, an effect that was not detected in the control group that was provided self-help materials. Although chatbots are a promising solution, there is limited scientific evidence for the efficacy of agent-guided cognitive behavioral therapy (CBT) outside the English language, especially for highly inflected languages.

Objective

This study aimed to measure the efficacy of Fido, a therapy chatbot that uses the Polish language. It targets depressive and anxiety symptoms using CBT techniques. We hypothesized that participants using Fido would show a greater reduction in anxiety and depressive symptoms than the control group.

Methods

We conducted a 2-arm, open-label, randomized controlled trial with 81 participants with subclinical depression or anxiety who were recruited via social media. Participants were divided into experimental (interacted with a fully automated Fido chatbot) and control (received a self-help book) groups. Both intervention methods addressed topics such as general psychoeducation and cognitive distortion identification and modification via Socratic questioning. The chatbot also featured suicidal ideation identification and redirection to suicide hotlines. We used self-assessment scales to measure primary outcomes, including the levels of depression, anxiety, worry tendencies, satisfaction with life, and loneliness at baseline, after the 2-week intervention and at the 1-month follow-up. We also controlled for secondary outcomes, including engagement and frequency of use.

Results

There were no differences in anxiety and depressive symptoms between the groups at enrollment and baseline. After the intervention, depressive and anxiety symptoms were reduced in both groups (chatbot: n=36; control: n=38), which remained stable at the 1-month follow-up. Loneliness was not significantly different between the groups after the intervention, but an exploratory analysis showed a decline in loneliness among participants who used Fido more frequently. Both groups used their intervention technique with similar frequency; however, the control group spent more time (mean 117.57, SD 72.40 minutes) on the intervention than the Fido group (mean 79.44, SD 42.96 minutes).

Conclusions

We did not replicate the findings from previous (eg, Woebot) studies, as both arms yielded therapeutic effects. However, such results are in line with other research of Internet interventions. Nevertheless, Fido provided sufficient help to reduce anxiety and depressive symptoms and decreased perceived loneliness among high-frequency users, which is one of the first pieces of evidence of chatbot efficacy with agents that use a highly inflected language. Further research is needed to determine the long-term, real-world effectiveness of Fido and its efficacy in a clinical sample. Trial Registration ClinicalTrials.gov NCT05762939; https://clinicaltrials.gov/study/NCT05762939; Open Science Foundation Registry 2cqt3; https://osf.io/2cqt3

Subjects

Author keywords

CBTRCTanxietyartificial intelligencechatbotchatbotscognitive behavioral therapycognitive distortionsconversational agentconversational agentsdepressiondepressivemental healthpsychotherapyrandomized control trial

Authors and institutions

  • Laboratory of Affective Neuroscience in Poznan, SWPS University, Warsaw, Poland.
  • Center for Research on Personality Development in Poznan, SWPS University, Warsaw, Poland.

ORCID profiles: Stanisław Karkosz, Robert Szymański, Katarzyna Sanna, Jarosław Michałowski

Cite

APA

Karkosz, S., Szymański, R., Sanna, K., & Michałowski, J. (2024). Effectiveness of a Web-based and Mobile Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: Randomized Controlled Trial. JMIR Formative Research, 8, e47960. https://doi.org/10.2196/47960

Vancouver

Karkosz S, Szymański R, Sanna K, Michałowski J. Effectiveness of a Web-based and Mobile Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: Randomized Controlled Trial. JMIR Formative Research. 2024;8:e47960. doi:10.2196/47960

BibTeX
@article{Karkosz2024,
  author = {Karkosz, Stanisław and Szymański, Robert and Sanna, Katarzyna and Michałowski, Jarosław},
  title = {Effectiveness of a Web-based and Mobile Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: Randomized Controlled Trial},
  journal = {JMIR Formative Research},
  year = {2024},
  volume = {8},
  pages = {e47960},
  doi = {10.2196/47960}
}
Start for free →